Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1022958-60-6 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 |
Formula Wt. | 539.08 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonym | CEP 28122, CEP28122 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
BCL-XL specific degrader
Peptide, involved in synapse formation and cell...
Natriuretic, vasodilatory peptide, bradykinin a...
Peptide; galanin antagonist.
Dual inhibitor of PI3K and mTOR.
JAK1 inhibitor.
Regioisomers
NSAID; COX-1/2 inhibitor.
Highly selective inhibitor
Isoquinoline alkaloid found in Corydalis; 5-HT1...
Coumarin; VKORC1 inhibitor.
GABA-A α5/3/2 positive modulator.
Endogenous peptide involved in vascular contrac...
SRPK1 inhibitor.
HIV protease, GLUT4, calpain inhibitor.
NMDA potentiator, GABA-A antagonist.
Amphiphilic properties
Hec1/Nek2 mitotic pathway inhibitor
Endogenous peptide hormone, involved in water h...
EGFR inhibitor.